Julie Tsai

Detection and Dynamic Changes of <i>EGFR</i> Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy

Tony Mok, Yi‐Long Wu, Jin Soo Lee et al. · Clinical Cancer Research · 2015 · 469 citations

Medicine, Oncology, Pharmacology +17

Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor‐sensitizing and resistance mutations in the plasma DNA of patients with advanced non–small cell lung cancer during treatment with erlotinib

Boe Sandahl Sørensen, Lin Wu, Wen Wei et al. · Cancer · 2014 · 193 citations · Full text

Medicine, Molecular Biology, Oncology +16

Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays

Britta Weber, Peter Meldgaard, Henrik Hager et al. · BMC Cancer · 2014 · 152 citations · Full text

Medicine, Molecular Biology, Oncology +17

Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance #

Qiaozhu Su, Julie Tsai, Elaine Xu et al. · Hepatology · 2009 · 117 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

MEK–ERK Inhibition Corrects the Defect in VLDL Assembly in HepG2 Cells

Julie Tsai, Wei Qiu, Rita Kohen-Avramoglu et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2006 · 78 citations

Life Sciences, Biochemistry, Molecular Biology +15